SOFTGEL CAPSULE
MANUFACTURER INDIA
FOR PHILIPPINES
WHO-GMP certified softgel capsules from Haryana, India — serving Philippine importers with FDA PH-ready documentation, Glutathione formulations, competitive pricing, and flexible order volumes.
PHILIPPINES PHARMACEUTICAL IMPORT LANDSCAPE
The Philippines is one of the world's top importers of softgel capsules — and India is its dominant supplier. Philippine pharmaceutical imports from India total approximately $443 million annually, with year-over-year growth of 15%. India accounts for 53% of the Philippines' softgel capsule imports, with approximately 3,870 recorded shipments, making India the single largest source country for Philippine softgel demand.
This trade relationship is structural and deepening. India offers WHO-GMP certified manufacturing at price points that Philippine distributors and consumers demand, with established shipping routes from Chennai and Mumbai to Manila. The Philippines' 115-million population, growing middle class, and increasing health consciousness are driving sustained demand for nutraceutical softgel imports across pharmacy retail, e-commerce, and institutional channels.
The Philippine nutraceutical softgel market has distinctive demand patterns. Glutathione supplements are a uniquely massive category — the Philippines is the world's largest Glutathione consumer market, driven by cultural demand for skin-lightening products. Beyond Glutathione, cardiovascular health supplements (Omega-3) are critical — cardiovascular disease is the leading cause of death in the Philippines, accounting for approximately 35% of all mortality. Multivitamins, Vitamin D3, and bone health formulations round out the high-demand softgel categories.
All pharmaceutical and nutraceutical imports into the Philippines must be registered with FDA Philippines — the Food and Drug Administration. FDA PH requires a License to Operate (LTO) for the importing entity and a Certificate of Product Registration (CPR) for each product, supported by an ACTD-format dossier, WHO-GMP certificate, and Certificate of Pharmaceutical Product (CPP) from CDSCO India. Indian manufacturers with WHO-GMP certification have a streamlined path through this regulatory framework.
FDA PHILIPPINES REGISTRATION PROCESS
FDA Philippines — the Food and Drug Administration — regulates all pharmaceutical and nutraceutical imports into the Philippines. The registration process requires a License to Operate (LTO) and a Certificate of Product Registration (CPR) for each product.
- 01
Obtain License to Operate (LTO)
FDA Philippines requires all entities involved in importing pharmaceutical and nutraceutical products to hold a valid License to Operate (LTO). The LTO is issued to the Philippine-based importing company — not the foreign manufacturer. The importer must apply for and maintain an active LTO before any product registration can proceed. This is the mandatory foundational step for importing softgel capsules into the Philippines.
- 02
Apply for Certificate of Product Registration (CPR)
Each specific product to be imported must have a Certificate of Product Registration (CPR) issued by FDA Philippines. The CPR application requires submission of the ACTD-format dossier (ASEAN Common Technical Document), which includes product formulation details, manufacturing process, quality control specifications, stability data, and labeling information. Admetus prepares the manufacturer's portion of the ACTD dossier for submission by the Philippine importer.
- 03
Submit ACTD-format dossier
The Philippines follows the ACTD (ASEAN Common Technical Document) format for product registration submissions. This standardized format covers five modules: administrative information, quality (chemistry, manufacturing, controls), safety, efficacy, and product labeling. Admetus provides the complete Module 3 (Quality) documentation including manufacturing process validation, analytical methods, stability data, and Certificate of Analysis templates.
- 04
Provide GMP certificate and CPP from CDSCO
FDA Philippines requires a valid GMP certificate (WHO-GMP is accepted) and a Certificate of Pharmaceutical Product (CPP) issued by the Central Drugs Standard Control Organisation (CDSCO) of India. The CPP confirms that the product is registered and freely sold in the country of origin. Admetus coordinates the CPP application with CDSCO and provides the authenticated WHO-GMP certificate as part of the registration package.
- 05
FDA PH evaluation and CPR issuance
Upon receiving the complete application — LTO verification, ACTD dossier, GMP certificate, and CPP — FDA Philippines evaluates the submission. This may include documentary review, laboratory testing of product samples, and verification of manufacturing compliance. Upon successful evaluation, FDA PH issues the Certificate of Product Registration (CPR), which authorizes import and sale of the specific product in the Philippines. The CPR is typically valid for 5 years and renewable.
WHY PHILIPPINE IMPORTERS CHOOSE US
WHO-GMP certification accepted by FDA Philippines
The Food and Drug Administration of the Philippines (FDA PH) recognizes WHO-GMP certification as evidence of manufacturing quality compliance. Admetus holds WHO-GMP certification for its Jind, Haryana facility, which streamlines the FDA PH product registration process. WHO-GMP status reduces the scope of additional manufacturing site inspections and accelerates the Certificate of Product Registration (CPR) application timeline.
Glutathione formulation expertise
The Philippines is the world's largest market for Glutathione supplements — driven by demand for skin-lightening and antioxidant health benefits. Glutathione softgel capsules are among the highest-volume nutraceutical imports into the Philippines. Admetus manufactures Glutathione softgel formulations (reduced L-Glutathione) with verified potency, stability data, and the documentation required for FDA PH registration of Glutathione-containing products.
Five international certifications
Beyond WHO-GMP, our facility holds FSSAI, GMP, HACCP, and Halal certifications. This multi-certification profile demonstrates compliance across food safety, pharmaceutical manufacturing, hazard control, and religious dietary standards — covering the documentation requirements of FDA Philippines and Filipino importers across different product categories.
Competitive pricing for the Philippine market
India is the #1 supplier of softgel capsules to the Philippines — 53% of all Philippine softgel imports originate from India. This dominance is driven by competitive pricing at WHO-GMP quality levels. Our Haryana facility operates with lower overhead than manufacturers in major Indian metros. Our direct-to-importer model enables pricing that allows Philippine distributors to maintain healthy retail margins in a price-conscious market.
Flexible MOQ and pilot orders
We understand that Philippine importers — particularly those registering new products with FDA PH — need flexibility in initial order sizes. We support pilot-volume orders for market testing and FDA PH sample submission, with the ability to scale to full-container loads once product registration and market demand are established. This flexibility is especially valuable for new-to-market formulations like specialty Glutathione or combination multivitamin products.
SOFTGEL FORMULATIONS FOR THE PHILIPPINE MARKET
Glutathione (Reduced L-Glutathione) Softgel Capsules
The Philippines is the world's largest consumer market for Glutathione supplements. Demand is driven by the skin-lightening and antioxidant properties of Glutathione, which has become a mainstream health and beauty product across all socioeconomic segments in the Philippines. Glutathione softgel capsules — both standalone and in combination with Vitamin C or Alpha Lipoic Acid — are among the top-selling nutraceutical imports. Filipino consumers strongly prefer branded Glutathione products with verifiable quality certifications.
Cholecalciferol (Vitamin D3) 60,000 IU
Despite the Philippines' tropical climate, Vitamin D deficiency is documented in Filipino populations — particularly among urban residents, office workers, and individuals who avoid sun exposure for skin-lightening purposes. Vitamin D3 softgel capsules are increasingly prescribed by Filipino physicians for deficiency treatment and are growing in the pharmacy retail channel as awareness of Vitamin D's role in immune function and bone health increases.
Omega-3 Fatty Acids + Vitamin E
Cardiovascular disease is the leading cause of death in the Philippines, accounting for approximately 35% of all deaths. The burden of heart disease, hypertension, and stroke is growing rapidly with urbanization and dietary shifts. Omega-3 softgel capsules are widely recommended by Filipino healthcare providers for cardiovascular risk management, cholesterol control, and anti-inflammatory support — making this one of the most consistently demanded softgel formulations in the Philippine market.
Multivitamin Softgel Capsules
The Philippines has a significant burden of micronutrient deficiency — iron, Vitamin A, zinc, and iodine deficiencies are prevalent, particularly among women and children. Multivitamin softgel capsules address multiple deficiencies in a single dosage form. The Philippine government's nutrition programs and growing consumer health awareness drive demand across both institutional and retail pharmacy channels.
Calcitriol + Calcium Citrate + Vitamin K2-7
Bone health formulations serve the Philippines' growing elderly population and women's health segment. Osteoporosis is an increasing concern, particularly among post-menopausal Filipino women. The Calcitriol-Calcium-K2 combination is prescribed by Filipino orthopedic specialists and endocrinologists for osteoporosis prevention and treatment, and is available through pharmacy retail for preventive supplementation.
We manufacture 10+ standard softgel formulations with custom formulation development on request. All products can be supplied under your brand name for the Philippine market. See our complete product catalog and private label service for full details.
DOCUMENTATION FOR FDA PH & CUSTOMS
Certificate of Analysis (COA)
Batch-specific quality certificate covering identity testing, assay, dissolution, microbial limits, heavy metals, and physical parameters. Required by FDA Philippines for product registration and by Philippine importers for each shipment's Bureau of Customs clearance.
Certificate of Pharmaceutical Product (CPP) from CDSCO
Issued by India's Central Drugs Standard Control Organisation, the CPP confirms that the product is registered and freely manufactured and sold in India. FDA Philippines requires a CPP from the country of origin as part of the product registration dossier. Admetus coordinates the CPP application with CDSCO.
WHO-GMP Certificate
World Health Organization Good Manufacturing Practice certificate for the manufacturing facility. FDA Philippines accepts WHO-GMP as baseline evidence of manufacturing quality — this certificate is a key document in the CPR application dossier and significantly reduces the likelihood of requiring a separate facility inspection.
ACTD-Format Quality Dossier (Module 3)
The ASEAN Common Technical Document Module 3 (Quality) section includes manufacturing process description, validation data, analytical method details, stability study results, and specifications. Admetus prepares this module for the Philippine importer to include in their FDA PH registration submission.
Stability Data & Shelf Life Documentation
Accelerated and real-time stability study data for each product under ICH climatic Zone IVb conditions (relevant to the Philippines' tropical climate). FDA PH requires stability data to verify shelf life claims. We provide stability protocols and results as part of the ACTD Module 3 documentation.
Commercial Invoice & Packing List
Detailed commercial invoice with FOB/CIF Manila pricing, HS codes, and payment terms. Packing list with batch numbers, quantities, net/gross weights, and container loading details. Required by the Philippine Bureau of Customs for import duty assessment and clearance at Manila ports.
INDIA TO PHILIPPINES SHIPPING ROUTE
The India-Philippines shipping corridor is well-established for pharmaceutical cargo, with regular container vessel services from Chennai and Mumbai to Manila.
- 01
Origin: Chennai Port or JNPT (Mumbai)
Products are dispatched from our Jind, Haryana facility to either Chennai Port or JNPT (Nhava Sheva) in Mumbai. Both ports have regular container services to Manila. Chennai Port offers slightly shorter transit times to Southeast Asian destinations. Cargo is consolidated, inspected, and cleared for export at the port's pharmaceutical cargo handling facilities.
- 02
Sea freight: India to Manila
Container vessel services from Chennai/JNPT to Manila operate on regular schedules with 10-14 days ocean transit time. Pharmaceutical cargo is shipped in standard dry containers with temperature monitoring for heat-sensitive products. Multiple shipping lines serve the India-Manila route with weekly departures, ensuring consistent supply chain reliability.
- 03
Destination: Manila International Container Terminal
Pharmaceutical imports arrive at Manila — typically at Manila International Container Terminal (MICT) or Manila South Harbor. Philippine Bureau of Customs clearance and FDA PH verification at the port typically take 3-7 business days. The importer's customs broker handles port-side clearance with the documentation package we provide (commercial invoice, packing list, COA, CPR evidence).
- 04
Packaging for tropical transit
All Philippines-bound shipments are packed in pharmaceutical-grade export packaging — blister packs or bottles in outer cartons, master cartons with desiccants and moisture barriers, tamper-evident sealing, and batch identification. Packaging is designed for tropical transit conditions and the Philippines' high-humidity environment. We coordinate with the buyer's freight forwarder or recommend trusted logistics partners for the India-Philippines corridor.
PHILIPPINES EXPORT Q&A
01What is required for FDA Philippines product registration of imported softgels?
FDA Philippines requires a Certificate of Product Registration (CPR) for every imported pharmaceutical and nutraceutical product. The CPR application requires: a valid License to Operate (LTO) held by the Philippine importer, an ACTD-format technical dossier, WHO-GMP certificate from the manufacturer, Certificate of Pharmaceutical Product (CPP) from CDSCO India, product samples for FDA PH laboratory testing, and product labeling in compliance with Philippine regulations. Admetus provides the complete manufacturer documentation package — WHO-GMP certificate, CPP coordination, ACTD Module 3 quality dossier, stability data, and COA — enabling Philippine importers to compile and submit their FDA PH registration application.
02What documentation does Admetus provide for Philippine import?
We provide the complete manufacturer documentation package for FDA Philippines registration: Certificate of Analysis (batch-specific), WHO-GMP certificate, coordination for Certificate of Pharmaceutical Product (CPP) from CDSCO, ACTD Module 3 quality dossier (manufacturing process, validation, analytical methods, stability data), product specifications, and commercial export documents (invoice, packing list, HS codes). We also provide product samples for FDA PH laboratory evaluation upon request. Our export team is experienced in preparing documentation for the Philippine regulatory environment.
03What is the MOQ for Philippines export orders?
MOQs are flexible and depend on the formulation, packaging format, and order configuration. For initial orders — particularly those tied to FDA PH registration and market testing — we offer pilot volumes. Once CPR is secured and market demand is established, we support full 20ft and 40ft container loads for ongoing supply. Specific MOQ and pricing are confirmed within 48 hours of inquiry at [email protected].
04Does Admetus manufacture Glutathione softgel capsules?
Yes. Admetus manufactures Glutathione softgel capsules using reduced L-Glutathione. The Philippines is the world's largest consumer market for Glutathione supplements, driven by demand for skin-lightening and antioxidant health benefits. We offer Glutathione in standalone formulations and in combination with Vitamin C, Alpha Lipoic Acid, or other synergistic ingredients. All Glutathione formulations are manufactured under WHO-GMP conditions with full stability data, COA, and the documentation required for FDA PH registration. Private label Glutathione softgels for the Philippine market are available.
05How long does shipping take from India to the Philippines?
Sea freight from Chennai Port or JNPT (Mumbai) to Manila — Manila International Container Terminal (MICT) or Manila South Harbor — takes approximately 10-14 days transit time. This is the standard shipping route for pharmaceutical cargo from India to the Philippines. After port arrival, customs clearance at Philippine ports typically takes 3-7 business days depending on documentation completeness and FDA PH verification. Total transit from factory dispatch to warehouse delivery in Manila is typically 20-30 days.
06Can Admetus supply private label softgels for the Philippine market?
Yes. We offer full private label and contract manufacturing services for the Philippine market. This includes custom formulation development, your brand name and artwork on packaging, FDA PH-compliant labeling, and all manufacturer documentation needed for CPR registration under your brand. Glutathione, Omega-3, Multivitamins, and Vitamin D3 are among the most commonly requested private label formulations for the Philippines. Minimum order quantities for private label are flexible — contact [email protected] for specific requirements and pricing.
START YOUR PHILIPPINES EXPORT ORDER
Contact our export team to discuss your Philippines import requirements — FDA PH documentation, Glutathione formulations, MOQ, pricing, and shipping. We respond within 48 hours.